Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early-Stage Lung Cancer”

493 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 493 results

Testing effectiveness (Phase 2)UnknownNCT04647357
What this trial is testing

A Trial of SHR-1316 Maintenance Therapy for Limited Stage Small Cell Lung Cancer

Who this might be right for
Limited-stage Small Cell Lung Cancer, LS-SCLC
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 60
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Not applicableLooking for participantsNCT07168993
What this trial is testing

Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.

Who this might be right for
Lung Cancer (Diagnosis)
bioAffinity Technologies Inc. 2,063
Testing effectiveness (Phase 2)Study completedNCT02581787
What this trial is testing

SABR-ATAC: A Trial of TGF-beta Inhibition and Stereotactic Ablative Radiotherapy for Early Stage Non-small Cell Lung Cancer

Who this might be right for
Stage IA Non-Small Cell Lung CarcinomaStage IB Non-Small Cell Lung Carcinoma
Maximilian Diehn 28
Testing effectiveness (Phase 2)Study completedNCT03673657
What this trial is testing

Study of Early Nutritional Intervention During Concurrent Chemoradiotherapy for Local Advanced Non-small Cell Lung Cancer

Who this might be right for
Local Advanced Non-small Cell Lung Cancer
Sun Yat-sen University 67
Not applicableLooking for participantsNCT03791034
What this trial is testing

Cell Free DNA for the Diagnosis and Treatment in Early NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Samsung Medical Center 700
Large-scale testing (Phase 3)UnknownNCT01731548
What this trial is testing

A Prospective Randomized Study Comparing the Target Volume for Limited-stage Small Cell Lung Cancer

Who this might be right for
Carcinoma of LungSmall CellLimited Stage
Zhejiang Cancer Hospital 500
Large-scale testing (Phase 3)UnknownNCT00002858
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Gustave Roussy, Cancer Campus, Grand Paris 280
Large-scale testing (Phase 3)Looking for participantsNCT04155034
What this trial is testing

S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer

Who this might be right for
Extensive Stage Lung Small Cell CarcinomaLimited Stage Lung Small Cell CarcinomaLung Small Cell Carcinoma
SWOG Cancer Research Network 668
Not applicableStudy completedNCT00003006
What this trial is testing

Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 501
Large-scale testing (Phase 3)Active Not RecruitingNCT05353257
What this trial is testing

Evaluate the Efficacy and Safety of Serplulimab in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung Cancer

Who this might be right for
Limited-Stage Small Cell Lung Cancer
Shanghai Henlius Biotech 511
Large-scale testing (Phase 3)Looking for participantsNCT07015892
What this trial is testing

Dose-Escalation Radiotherapy in Limited-Stage Small Cell Lung Cancer: A Phase III Randomized Trial

Who this might be right for
Small Cell Lung Carcinoma
Instituto de Investigación Biomédica de Salamanca 300
Testing effectiveness (Phase 2)Looking for participantsNCT06719700
What this trial is testing

Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer

Who this might be right for
ToripalimabSurufatinibChemoradiotherapy+1 more
Sun Yat-sen University 47
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06914050
What this trial is testing

Hypofractionated Radiotherapy Followed by Chemo-immunotherapy Induction Therapy

Who this might be right for
Lung Cancer, Small CellLimited-stage Small Cell Lung Cancer (LS-SCLC)
Tianjin Medical University Cancer Institute and Hospital 30
Not applicableStudy completedNCT00897793
What this trial is testing

Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+2 more
Vanderbilt-Ingram Cancer Center 25
Not applicableUnknownNCT06341387
What this trial is testing

Volatolomic and Proteomic Profile for Early Diagnosis of Lung Cancer

Who this might be right for
Lung CancerNon-small Cell Lung Cancer Stage INon-small Cell Lung Cancer Stage II+1 more
European Institute of Oncology 200
Testing effectiveness (Phase 2)Ended earlyNCT04447235
What this trial is testing

Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 Infection

Who this might be right for
CancerCOVIDCoronavirus Infection
Instituto do Cancer do Estado de São Paulo 77
Testing effectiveness (Phase 2)Looking for participantsNCT06088771
What this trial is testing

Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Icahn School of Medicine at Mount Sinai 21
Testing effectiveness (Phase 2)Study completedNCT00963807
What this trial is testing

A Comparison of FLT to FDG PET/CT in the Early Assessment of Chemotherapy Response in Stage IB-IIIA Resectable NSCLC

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage IB Non-Small Cell Lung CarcinomaStage IIA Non-Small Cell Lung Carcinoma+3 more
National Cancer Institute (NCI) 26
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06978153
What this trial is testing

This is a Two-cohort, Exploratory Clinical Study Assessing the Activity of Benmelstobart Combined With Chemotherapy With or Without Anlotinib in Resectable Limited-Stage Small Cell Lung Cancer

Who this might be right for
Limited Stage Small Cell Lung Cancer
Tang-Du Hospital 66
Load More Results